Financials
Value Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 1.59 M3.85 M3.69 M — Research & development 181.64 K397.14 K473.56 K — Operating income -2.26 M-4.22 M-2.19 M — Non-Operating Income, Total -26.6 M0-163.8 K — Interest expense, net of interest capitalized 168.76 K075.86 K — Non-Operating Income, excl. Interest Expenses -26.77 M0-239.66 K — Unusual income/expense ——— — Pretax income -28.86 M-4.22 M-2.36 M — Equity in earnings ——— — Taxes 000 — Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations -28.86 M-4.22 M-2.36 M — Discontinued operations ——— — Net income -28.86 M-4.22 M-2.36 M — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders -28.86 M-4.22 M-2.36 M — Basic earnings per share (Basic EPS) -2-0.150.63 — Diluted earnings per share (Diluted EPS) -2-0.15-0.11 — Average basic shares outstanding 14.41 M27.65 M20.58 M — Diluted shares outstanding 14.41 M27.65 M20.58 M — EBITDA -2.22 M—— — EBIT -2.26 M-4.22 M-2.19 M — Cost of revenue 67.19 K488.29 K2.56 M — Other cost of goods sold ——— — Depreciation & amortization (cash flow) 31.64 K—— —